GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization-Reference-Cited by-同舟云学术

GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization

Published:2010-12 Issue:2 Volume:203 Page:215-221
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Koh Youngil,Kim Dae-Young,Park Sung-Hyo,Jung Seung-Hyun,Park Eunkyung,Kim Hyeoung-Joon,Sohn Sang Kyun,Joo Young Don,Kim Seok Jin,Shin Ho-Jin,Kim Sung-Hyun,Song Hong Suk,Chung Jooseop,Kim Inho,Yoon Sung-Soo,Kim Byoung Kook,Shin Seung-Hun,Chung Yeun-Jun,Park Seonyang

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference23 articles.

1. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

2. ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring;Hughes;Hematology Am Soc Hematol Educ Program,2006

3. Clinical resistance to imatinib: mechanisms and implications;Hochhaus;Hematol Oncol Clin North Am,2004

4. IRIS investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

5. Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment;Chu;Blood,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia;PLOS ONE;2017-09-13

2. Effect of Glutathione S-transferase mu 1 ( GSTM1 ) gene polymorphism on chronic myeloid leukemia risk and Imatinib treatment response;Meta Gene;2017-06

3. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors;Journal of Surgical Oncology;2015-03-13

4. Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia;Clinical Pharmacology & Therapeutics;2014-09-04

5. Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinib;Medical Oncology;2014-06-10